Year 2020 / Volume 112 / Number 6
Special Article
Main prophylactic measures in bariatric endoscopy. Spanish Expert Recommendations Guideline

491-500

DOI: 10.17235/reed.2020.6970/2020

Eduardo Espinet Coll, Román Turró Arau, Aitor Orive Calzada, Carlos Dolz Abadía, Amador García Ruiz de Gordejuela, Andrés Sánchez Yagüe, Javier Nebreda Durán, Manoel Galvao Neto, Gontrand López-Nava Breviere, Alfredo Mata Bilbao, Alfonso Alcalde Vargas, Ramón Abad Belando, Andrés José del Pozo-García, José Miguel Esteban López-Jamar, Jordi Pujol Gebelli, Antonio José Torres García, José Antonio Ramírez Felipe, Miguel Muñoz Navas,

Abstract
Bariatric endoscopy (BE) encompasses a number of techniques —some consolidated, some under development— aiming to contribute to the management of obese patients and their associated metabolic diseases as a complement to dietary and lifestyle changes. To date different intragastric balloon models, suture systems, aspiration methods, substance injections and both gastric and duodenal malabsorptive devices have been developed, as well as endoscopic procedures for the revision of bariatric surgery. Their ongoing evolution conditions a gradual increase in the quantity and quality of scientific evidence about their effectiveness and safety. Despite this, scientific evidence remains inadequate to establish strong grades of recommendation allowing a unified perspective on prophylaxis in BE. This dearth of data conditions leads, in daily practice, to frequently extrapolate the measures that are used in bariatric surgery (BS) and/or in general therapeutic endoscopy. In this respect, this special article is intended to reach a consensus on the most common prophylactic measures we should apply in BE. The methodological design of this document was developed while attempting to comply with the following 5 phases: Phase 1: delimitation and scope of objectives, according to the GRADE Clinical Guidelines. Phase 2: setup of the Clinical Guide-developing Group: national experts, members of the Grupo Español de Endoscopia Bariátrica (GETTEMO, SEED), SEPD, and SECO, selecting 2 authors for each section. Phase 3: clinical question form (PICO): patients, intervention, comparison, outcomes. Phase 4: literature assessment and synthesis. Search for evidence and elaboration of recommendations. Based on the Oxford Centre for Evidence-Based Medicine classification, most evidence in this article will correspond to level 5 (expert opinions without explicit critical appraisal) and grade of recommendation C (favorable yet inconclusive recommendation) or D (inconclusive or inconsistent studies). Phase 5: External review by experts. We hope that these basic preventive measures will be of interest for daily practice, and may help prevent medical and/or legal conflicts for the benefit of patients, physicians, and BE in general.
Share Button
New comment
Comments
No comments for this article
References
1. Gould MK. Prevention of VTE in Nonorthopedic Surgical Patients. CHEST J. 2012;141(2_suppl): e227S, Doi: 10.1378/chest.11-2297.
2. Guyatt GH., Akl EA., Crowther M., et al. Executive summary: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 SUPPL.):7-47, Doi: 10.1378/chest.1412S3.
3. Vandiver JW., Ritz LI., Lalama JT. Chemical prophylaxis to prevent venous thromboembolism in morbid obesity: literature review and dosing recommendations. J Thromb Thrombolysis. 2016;41(3):475-81, Doi: 10.1007/s11239-015-1231-5.
4. Espinet-Coll E., Nebreda-Durán J., Gómez-Valero JA., et al. Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig. 2012; 104:72-87, Doi: 10.4321/S1130-01082012000200006.
5. Llau Pitarch J.V., Arcelus Martínez J.I., Castellet Feliu E, et al. Recomendaciones de tromboprofilaxis en Cirugía Mayor Ambulatoria. Documento multidisciplinar de consenso de la Asociación Española de Cirugía Mayor Ambulatoria (ASECMA). CIR MAY AMB. 2016;21(1):25-36.
6. Jamal MH., Corcelles R., Shimizu H., et al. Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience. Surg Endosc. 2014;29(2):376-80, Doi: 10.1007/s00464-014-3678-4.
7. Genco A., López-Nava G., Wahlen C., et al. Multi-Centre european experience with intragastric balloon in overweight populations: 13 years of experience. Obes Surg. 2013;23(4):515-21, Doi: 10.1007/s11695-012-0829-3.
8. López-Nava G., Bautista-Castaño I., Jiménez A., et al. The Primary Obesity Surgery Endolumenal (POSE) procedure: one-year patient weight loss and safety outcomes. Surg Obes Relat Dis. 2014;11(4):861-5, Doi: 10.1016/j.soard.2014.09.026.
9. López-Nava G., Galvao M., Bautista-Castaño I., et al. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int open. 2016;4(2): E222-7, Doi: 10.1055/s-0041-110771.
10. Vilarrasa N., de Gordejuela AGR., Casajoana A., et al. Endobarrier® in Grade I Obese Patients with Long-Standing Type 2 Diabetes: Role of Gastrointestinal Hormones in Glucose Metabolism. Obes Surg. 2017;27(3):569-77, Doi: 10.1007/s11695-016-2311-0.
11. Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70:195e283.
12. Pories WJ, Van Rij AM, Burlingham BT, et al. Prophylactic cefazolin in gastric bypass surgery. Surgery. 1981; 90:426-32.
13. Preclik G, Grüne S, Leser HG, et al. Prospective, randomized, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ. 1999; 319:881-4.
14. Fischer MI, Dias C, Stein AT, et al. Antibiotic prophylaxis in obese patients submitted to bariatric surgery. A systematic review. Acta Cirúrgica Brasileira; 2014; 29 (3): 209-217.
15. Banerjee S, Shen B, Baron TH, for the American Society for Gastrointestinal Endoscopy Standards of Practice Committee. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2008; 67:791-8.
16. Rey JR, Axone A, Budzynska A, et al. Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy. Endoscopy. 1998; 30:318-24.
17. Christou NV, Jarand J, Sylvestre JL, et al. Analysis of the incidence and risk factors for wound infections in open bariatric surgery. Obes Surg. 2004; 14:16-22.
18. Uchiyama K, Takifuji K, Tani M, et al. Prevention of postoperative infections by administration of antimicrobial agents immediately before surgery for patients with gastrointestinal cancers. Hepatogastroenterology. 2007; 54:1487-93.
19. Anderson DJ, Podgorny K, Berrios-Torres SI, et al. Strategies to prevent surgical site infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35:605e627.
20. Steinberg JP, Braun BI, Hellinger WC, et al. Timing of antimicrobial prophylaxis and the risk of surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis Errors. Ann Surg 2009; 250:10e16.
21. Hawn MT, Richman JS, Vick CC, et al. Timing of surgical antibiotic prophylaxis and the risk of surgical site infection. JAMA Surg 2013; 148:649e657.
22. Peppard William J., Eberle David G., Kugler Nathan W., et al. Association between Pre-Operative Cefazolin Dose and Surgical Site Infection in Obese Patients. Surg Infect. 2017 May/Jun;18(4):485-490. doi: 10.1089/sur.2016.182. Epub 2016 Dec 1.
23. El-Hayek K, Timratana P, Shimizu H, et al. Marginal ulcer after Roux-en-Y gastric bypass: what have we really learned ? Surg Endosc 2012; 26: 2789-96.
24. Mechanick JI, Youdim A, Jones DB, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient -- 2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring). 2013 Mar; 21 Suppl 1: S1-27.
25. Chan FK, Wong VW, Suen BY, et al. Combination of a cyclo-oxygenase-2 inhibitor and a proton-pump inhibitor for prevention of recurrent ulcer bleeding in patients at very high risk: a double-blind, randomised trial. Lancet. 2007; 369:1621-6.
26. ASGE Standards of Practice Committee, Acosta RD, Abraham NS, Chandrasekhara V, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016; 83(1):3-16.
27. Gralnek IM, Dumonceau JM, Kuipers EJ, et al. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 1–46.
28. Espinós JC, Turró R, Mata A, et al. Early experience with the Incisionless Operating Platform (IOP) for the treatment of obesity: the Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg 2013; 23(9): 1375-83.
29. Espinet Coll E, Nebreda Durán J, López-Nava Breviere G, et al. Multicenter study on the safety of bariatric endoscopy. Rev Esp Enferm Dig. 2017; 109(5): 350-357.
30. López-Nava G, Sharaiha RZ, Vargas EJ, et al. Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg. 2017; 27(10): 2649-2655.
31. Kumar N, Thompson CC. Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up. Gastrointest Endosc 2016; 83(4):776-9.
32. Thompson CC, Abu Dayyeh BK, Kushner K, et al. Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial. Am J Gastroenterol. 2017; 112(3):447-457.
33. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc 2010; 71(6): 976-82.
34. Abu-Dayyeh B. A randomized, multi-center study to evaluate the safety and effectiveness of the orbera intragastric balloon as an adjunct to a behavioral modification program. In: Comparison with a Behavioral Modification Program Alone in the Weight Management of Obese Subjects. Rochester, MN: Mayo Clinic; 2015 (Publication Pending). Online at: http://www.orbera.com/resource/1441904169000/o_orbera_code/pdf/ORBERA_Directions_for_Use_GRF-00346-00R01.pdf.)
35. Ponce J, Quebbemann BB, Patterson EJ. Prospective, randomized, multicenter study evaluating safety and efficacy of intragastric dual-balloon in obesity. Surg Obes Relat Dis 2013; 9(2): 290-5.
36. Larrad A, Sánchez-Cabezudo C. Indicadores de calidad en cirugía bariátrica y criterios de éxito a largo plazo. Cir Esp 2004; 75: 301-4.
37. Rubio MA, Martínez C, Vidal O, et al. Documento de consenso sobre cirugía bariátrica. Rev Esp Obes 2004; 4: 223-249.
38. Espinet Coll E, López-Nava Breviere G, Nebreda Durán J, et al. Documento español de consenso en endoscopia bariátrica. Parte 1. Consideraciones generales. Rev Esp Enferm Dig 2018;110(6): 386-399.
39. Bruguera M, Viger M, Bruguera R, et al. Reclamaciones por presunta negligencia relacionadas con endoscopia digestiva. Análisis de una casuística de 22 años. Gastroenterol Hepatol 2011; 34(4):248-253.
40. Ley 41/2002, de 14 de noviembre, Básica Reguladora de la Autonomía del Paciente y de Derechos y Obligaciones en Materia de Información y Documentación Clínica. Boletín Oficial del Estado, núm. 274 de 15 de noviembre de 2002. p. 40126-132.
41. García Ruiz De Gordejuela A, Madrazo González Z, Casajoana Badia A, et al. Descripción de la asistencia en urgencias de pacientes intervenidos de cirugía bariátrica en un centro de referencia. Rev Esp Enferm Dig 2015; 107: 23-28.
42. Brethauer SA, Chand B, Schauer PR. American Society for Metabolic and Bariatric Surgery (ASMBS) Centers of Excellence Program. In: Nguyen NT, Maria EJ, Ikramuddin S, Hutter MM, editors. The SAGES manual. New York: Springer; 2008. p. 257–60.
43. American Society for Gastrointestinal Endoscopy: establishment of gastrointestinal endoscopy areas. Gastrointest Endosc 1999; 50: 910–2.
44. American Society for Gastrointestinal Endoscopy: role of endoscopy in the bariatric surgery patient. Gastrointest Endosc 2008; 68: 1–10.
45. Dolz Abadía C, de Lorenzo Aparici O. Aspectos médico-legales de la endoscopia digestiva. Congreso de la SEED. Zaragoza 2015. Rev Esp Enferm Dig 2016; 108(2): 4-7.
46. Dolz Abadía C. Consentimiento informado en endoscopia digestiva: información para el paciente, protección para el endoscopista. Rev Esp Enferm Dig 2016; 108 (2): 13-23.
47. Kvitko LA. Rev Lat Der Med Legal 2002; 7:77-80.
48. Andreu E, Azparren A, Donat E. Estudio jurisprudencial en medicina satisfactiva. Rev Esp Med Legal 2001; 39:162-7.
49. Nebreda J, Espinet E, GETTEMO. Posicionamiento de GETTEMO sobre las técnicas endoscópicas bariátricas consideradas como medicina satisfactiva. Rev Esp Enferm Dig 2017; 109 (12): 875-876.
50. Vila JJ, Jiménez FJ, Iñarrairaegui M, et al. Informed consent document in gastrointestinal endoscopy: Understanding and acceptance by patients. Rev Esp Enferm Dig 2006; 98:101-11.
Related articles

Letter

Hepatitis B virus reactivation after ibrutinib treatment

DOI: 10.17235/reed.2023.9587/2023

Letter to the Editor

GETTEMO position statement on bariatric endoscopic techniques as a voluntary medicine

DOI: 10.17235/reed.2017.5144/2017

Original

Multicenter study on the safety of bariatric endoscopy

DOI: 10.17235/reed.2017.4499/2016

Citation tools
Espinet Coll E, Turró Arau R, Orive Calzada A, Dolz Abadía C, García Ruiz de Gordejuela A, Sánchez Yagüe A, et all. Main prophylactic measures in bariatric endoscopy. Spanish Expert Recommendations Guideline. 6970/2020


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1459 visits.
This article has been downloaded 355 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 13/02/2020

Accepted: 29/02/2020

Online First: 26/05/2020

Published: 08/06/2020

Article revision time: 8 days

Article Online First time: 103 days

Article editing time: 116 days


Share
This article has been rated by 5 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology